Clinical Trials in California

Showing 4341-4360 of 11,359 trials

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

NCT03195140

A 6-week crossover study will compare PLGS to SAP outcomes in adults and youth \> 6 years old with type 1 diabetes (T1D).

Diabetes Mellitus, Type 1

Tandem Diabetes Care, Inc.103 participantsStarted Aug 2017

Palo Alto, California, United States • Santa Barbara, California, United States • Aurora, Colorado, United States +1 more locations

COMPLETEDPhase 3135 miles

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

NCT02914561

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a separate long-term extension (LTE) study (Study GS-US-419-3896).

Crohn's Disease

Lakefront Biotherapeutics NV1,372 participantsStarted Oct 2016

Dothan, Alabama, United States • Sun City, Arizona, United States • Coronado, California, United States +510 more locations

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Find Trials by Condition in California

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

Intranasal Oxytocin for Frontotemporal Dementia

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Approaches and Decisions for Acute Pediatric TBI Trial

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

The Canadian/US Integrative Oncology Study

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

iCanCope With Sickle Cell Pain

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant